Skip to main content
Amoy Diagnostics Co.,Ltd. logo

Amoy Diagnostics Co.,Ltd. — Investor Relations & Filings

Ticker · 300685 ISIN · CNE1000034D3 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,088 across all filing types
Latest filing 2021-07-25 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300685

About Amoy Diagnostics Co.,Ltd.

https://www.amoydx.com

Amoy Diagnostics Co., Ltd. specializes in the development and commercialization of molecular diagnostic products for precision oncology. The company provides a comprehensive portfolio of testing kits designed to identify genetic mutations and biomarkers essential for personalized cancer treatment. Its core technology platforms include the proprietary ADx-ARMS, Super-ARMS, and specialized Next-Generation Sequencing (NGS) solutions. AmoyDx focuses on companion diagnostics (CDx), collaborating extensively with global pharmaceutical companies to integrate diagnostic testing into clinical drug development and patient management. Key products cover a wide range of solid tumors, including lung, colorectal, and breast cancers, facilitating targeted therapy selection and monitoring. The company maintains rigorous quality standards, with numerous products receiving regulatory approvals for clinical use in multiple international markets.

Recent filings

Filing Released Lang Actions
独立董事提名人声明（二）
Board/Management Information Classification · 95% confidence The document is a formal statement from the board of directors nominating an independent director candidate for the company. It includes detailed declarations about the nominee's qualifications, compliance with relevant laws and regulations, and independence criteria. There are no financial statements, earnings data, or report attachments. The content is focused on board/management information, specifically about a director nomination. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 4746 characters, which is sufficient for a detailed announcement but does not constitute a full report like an annual report or interim report.
2021-07-25 Chinese
独立董事提名人声明（一）
Board/Management Information Classification · 95% confidence The document is a public statement from the board of directors nominating an independent director candidate for the company's board. It details the nominee's qualifications, compliance with regulatory requirements, and independence criteria. There is no financial data, earnings information, or report publication mentioned. The content focuses on board/management information, specifically the nomination of a board member. Therefore, the document fits the category of Board/Management Information (MANG). The document length is sufficient and contains detailed information about the nominee, not just an announcement or a brief notice.
2021-07-25 Chinese
关于董事会换届选举的公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the election and nomination of the company's new board of directors. It details the candidates for the third board, their qualifications, and compliance with relevant laws and regulations. There is no financial data, earnings information, or report publication mentioned. The content focuses on board changes and nominations, which fits the category of Board/Management Information (MANG). The document length is 4527 characters, which is sufficient for a detailed announcement but not a full report. Therefore, the classification is MANG with high confidence.
2021-07-25 Chinese
2021年半年度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled "厦门艾德生物医药科技股份有限公司2021 年半年度报告全文" which translates to "Xiamen Amoy Diagnostics Co., Ltd. 2021 Semi-Annual Report Full Text." It explicitly states it is a half-year report covering the period from January 1, 2021 to June 30, 2021. The content includes detailed financial data, management discussion and analysis, business overview, risk factors, and other comprehensive information typical of an interim or quarterly report. The document length is about 15,000 characters, indicating it is a full report rather than a brief announcement. There is no indication that this is an announcement of a report or a certification document. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2021
2021-07-25 Chinese
独立董事候选人声明（苏文金）
Regulatory Filings Classification · 95% confidence The document is a detailed declaration by an independent director candidate of a company, confirming compliance with various legal and regulatory requirements for serving as an independent director. It includes statements about qualifications, independence, and adherence to relevant laws and regulations. There is no financial data, no report of financial results, no voting results, no management changes, no capital updates, or other typical financial or corporate event disclosures. This type of document is a regulatory compliance filing related to director qualifications and disclosures, but it is not a report or announcement of a meeting or financial results. It fits best under Regulatory Filings (RNS) as a compliance statement that does not fit other categories.
2021-07-25 Chinese
独立董事关于相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on various corporate governance matters including the absence of related party fund occupation, external guarantees, use of raised funds, nomination of board members for the third board, and remuneration standards for directors. It references compliance with company law, stock exchange guidelines, and internal company rules. The content focuses on board nominations, director qualifications, and remuneration proposals, which are typical topics for Board/Management Information filings. The document length is 2200 characters, which is relatively short and does not contain financial statements or detailed financial data, so it is not an Annual Report or Interim Report. It is not a voting result announcement or a proxy solicitation. Therefore, the best fit is Board/Management Information (MANG).
2021-07-25 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.